PlexusDx's marketing principle states clearly: your dose may need to go up, your price won't
The potential for gastrointestinal adverse effects, particularly nausea and vomiting, may lead to dehydration and worsening of renal function in vulnerable patients
A supplier reporting 5060% EE% is delivering a product where nearly half the active is already unprotected before your manufacturing process begins
doi: 10.1016/S0140-6736(20)32511-3 Summary Keywords chronic liver disorder, metabolic syndrome, non-alcoholic fatty liver disease, oxidative stress, oral glutathione Citation Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV and Di Sabatino A (2023) Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
Sed in purus vulputate sem tempor tincidunt ac sed turpis